Becker’s Hospital Review: PBMs LucyRx, Abarca Finalize Strategic Combination

Becker’s Hospital Review reported that LucyRx and Abarca Health completed their strategic combination. The article noted that the companies serve more than 9 million members across commercial and government markets and will maintain their independent brands, leadership and client relationships.

The coverage is important because it confirms the deal moved from announcement to completion. It also reinforces the strategic fit between LucyRx’s employer focus and clinical capabilities and Abarca’s integrated claims and benefits platform, Darwin.

Read the full article in Becker’s Hospital Review: PBMs LucyRx, Abarca finalize strategic combination

Read the Article

Download the PBM Reform Readiness Checklist

Download the GLP-1 Planning Checklist